Mayo Clinic Cancer Center is one of 40 U.S. medical centers that have met rigorous standards for designation as a comprehensive cancer center by the National Cancer Institute. Mayo also leads the North Central Cancer Treatment Group (NCCTG), which brings clinical trials with promising new cancer therapies, including for lung cancer, to communities where patients live.
Mayo Clinic researchers are actively involved in studies to help improve early detection of lung cancer, and quality of life and treatment options for patients. They have discovered that some genetic factors could influence the course of lung cancer, including treatment response, disease progression, development of new cancer and survival. Researchers are working to determine how genetic traits can be tested to guide individualized treatment for each patient with lung cancer.
Read more about the Epidemiology and Genetics of Lung Cancer Research Program.
See a list of publications by Mayo Clinic doctors on lung cancer on PubMed, a service of the National Library of Medicine.